mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Rescue therapy for acute migraine, part 3: opioids, nsaids, steroids, and post-discharge medications

Kelley NE et al. – The overall percentage of patients with pain relief after taking sumatriptan was equivalent to that observed with droperidol or prochlorperazine.

Methods
  • Using the terms (“migraine” AND “emergency”) AND (“therapy” OR “treatment”), the author searched MEDLINE for reports from ED and urgent care settings that involved all routes of medication delivery.
  • Reports from headache clinic settings were included only if medications were delivered by a parenteral route.

Results
  • Seventy–five reports were identified that compared the efficacy and safety of multiple acute migraine medications for rescue.
  • Of the medications reviewed in Part 3, opioids, NSAIDs, and steroids all demonstrated some effectiveness.
  • When used alone, nalbuphine and metamizole were superior to placebo.
  • NSAIDs were inferior to the combination of metoclopramide and diphenhydramine.
  • Meperidine was arguably equivalent when compared with ketorolac and dihydroergotamine (DHE) but was inferior to chlorpromazine and equivalent to the other dopamine antagonists.
  • Steroids afford some protection against headache recurrence after the patient leaves the treatment center. /li>
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close